1609030-89-8

Basic information

• Product Name: (E)-3-(3,4-bis(2-hydroxyethoxy)phenyl)-N-(2-(2-methyl-1H-indol-3-yl)ethyl)acrylamide
• Synonyms: (E)-3-(3,4-bis(2-hydroxyethoxy)phenyl)-N-(2-(2-methyl-1H-indol-3-yl)ethyl)acrylamide
• CAS NO: 1609030-89-8
• Molecular Weight: 424.497
• Mol File: 1609030-89-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (E)-3-(3,4-bis(2-hydroxyethoxy)phenyl)-N-(2-(2-methyl-1H-indol-3-yl)ethyl)acrylamide(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-3-(3,4-bis(2-hydroxyethoxy)phenyl)-N-(2-(2-methyl-1H-indol-3-yl)ethyl)acrylamide(1609030-89-8)
• EPA Substance Registry System: (E)-3-(3,4-bis(2-hydroxyethoxy)phenyl)-N-(2-(2-methyl-1H-indol-3-yl)ethyl)acrylamide(1609030-89-8)

Safety Data

• Hazardous Substances Data: 1609030-89-8(Hazardous Substances Data)

Upstream product

• 74257-25-3 ethyl caffeate 
• 1609031-14-2 ethyl (E)-3-(3,4-Bis(2-((tert-butyldimethylsilyl)oxy)ethoxy)phenyl)acrylate 
• 2731-06-8 2-methyltryptamine 
• 1609031-15-3 (E)-3-(3,4-bis(2-hydroxyethoxy)phenyl)acrylic Acid 

Relevant articles and documents

PROSTAGLANDIN RECEPTOR EP2 ANTAGONISTS, DERIVATIVES, COMPOSITIONS, AND USES RELATED THERETO

The disclosure relates to Prostaglandin receptor EP2 antagonists, derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing conditions and diseases in which EP2 receptor activation has a physiological role, such as but not limited to, brain injury, inflammatory diseases, neuroinflamation after a seizure, pain, endometriosis, cancer, rheumatoid arthritis, skin inflammation, vascular inflammation, colitis, and neurological disorders by administering a pharmaceutical composition comprising a compound disclosed herein to a subject in need thereof.